Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.
about
The Effectiveness of Intensity Modulated Radiation Therapy versus Three-Dimensional Radiation Therapy in Prostate Cancer: A Meta-Analysis of the LiteraturesLate rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelEstimation of α/β for late rectal toxicity based on RTOG 94-06Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment.Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design.Better survival with three-dimensional conformal radiotherapy than with conventional radiotherapy for cervical cancer: a population-based study.Soy isoflavones in conjunction with radiation therapy in patients with prostate cancerA comparison of HDR brachytherapy and IMRT techniques for dose escalation in prostate cancer: a radiobiological modeling study.Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding.Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer.Health-related quality of life using intensity-modulated radiation therapy for post-prostatectomy radiotherapy.Association between rectal bleeding and the absolute dose volume of the rectum following image-guided radiotherapy for patients with prostate cancer.
P2860
Q28552007-9856DFE9-3406-4354-AC18-44A2D1E9121BQ34238364-70B1B7B9-8AA8-4F38-ADC7-87E4283C5B0CQ35186584-EBD2D7C9-DFF3-4F7B-8006-8AD08E8EC0FFQ36364403-083BF5DE-9781-4094-89D0-F7F36D154817Q37110245-87A2A7BA-5039-4466-B4D1-A43031D6BAC7Q37256280-4F4A1FBC-C30E-4BCF-8294-96B5E2BD6226Q37376217-27E530D3-F020-470D-83D2-71084750DCC8Q41887636-E59E8B85-BF82-4FB7-A514-E927EF8715E1Q42571229-5C1F68A3-95C9-4D45-8CDB-8E58B920DE50Q44653206-02B41A51-89B2-44AD-A476-67632747CABFQ48306089-1CF6731D-27CD-46FD-898B-74D3969A9296Q55663443-756C9A38-0F17-4F20-A7D5-BDC4A690DA4A
P2860
Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Preliminary evaluation of low- ...... TOG 9406 dose levels I and II.
@en
Preliminary evaluation of low- ...... TOG 9406 dose levels I and II.
@nl
type
label
Preliminary evaluation of low- ...... TOG 9406 dose levels I and II.
@en
Preliminary evaluation of low- ...... TOG 9406 dose levels I and II.
@nl
prefLabel
Preliminary evaluation of low- ...... TOG 9406 dose levels I and II.
@en
Preliminary evaluation of low- ...... TOG 9406 dose levels I and II.
@nl
P2093
P1476
Preliminary evaluation of low- ...... TOG 9406 dose levels I and II.
@en
P2093
Alan Pollack
Arnold M Markoe
Carlos A Perez
Howard M Sandler
James A Purdy
James D Cox
Jeff M Michalski
Kathryn Winter
Matthew B Parliament
Richard B Wilder
P304
P356
10.1016/S0360-3016(03)00072-5
P407
P50
P577
2003-05-01T00:00:00Z